MARKET

BIXT

BIXT

Bioxytran Inc
OTCMQB
0.090
0.000
0.00%
Closed 10:23 07/11 EDT
OPEN
0.090
PREV CLOSE
0.090
HIGH
0.090
LOW
0.090
VOLUME
2.00K
TURNOVER
180
52 WEEK HIGH
0.220
52 WEEK LOW
0.062
MARKET CAP
8.00M
P/E (TTM)
-3.2727
1D
5D
1M
3M
1Y
5Y
1D
MP Materials Secures Transformative DoD Partnership to Boost U.S. Rare Earth Magnet Production
Reuters · 3d ago
Weekly Report: what happened at BIXT last week (0630-0704)?
Weekly Report · 6d ago
Weekly Report: what happened at BIXT last week (0623-0627)?
Weekly Report · 06/30 11:14
Weekly Report: what happened at BIXT last week (0616-0620)?
Weekly Report · 06/23 11:06
Bioxytran Secures a Source of GMP Quality Camel Hemoglobin
Barchart · 06/18 09:50
Weekly Report: what happened at BIXT last week (0609-0613)?
Weekly Report · 06/16 11:13
Weekly Report: what happened at BIXT last week (0602-0606)?
Weekly Report · 06/09 11:15
Bioxytran’s Groundbreaking Stroke & Alzheimer’s Tech Gains Validation That Measures Oxygenation Uptake During Strokes
Barchart · 06/03 08:12
More
About BIXT
Bioxytran, Inc. is a clinical-stage pharmaceutical company. The Company is focused on the development, manufacture, and commercialization of therapeutic drugs designed to address hypoxia in humans. The Company's lead drug candidate, code named BXT-25, is an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer with intended applications, which includes the treatment of hypoxic conditions in the brain resulting from stroke. The Company, through its subsidiary, Pharmalectin Inc., is focused on the development, manufacturing, and commercialization of therapeutic drugs designed to address viral diseases in humans. Pharmalectin Inc. has developed a method designed to reduce the viral load and modulate the immune system using a galectin inhibitor. Its lead drug candidate, named ProLectin-Rx, is a complex polysaccharide derived from pectin that binds to, and blocks the activity of galectin-1, a type of galectin.

Webull offers Bioxytran Inc stock information, including OTCMQB: BIXT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIXT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIXT stock methods without spending real money on the virtual paper trading platform.